Human SIRT1/SIR2/SIR2alpha ORF/cDNA clone-Adenovirus plasmid (NM_012238.4)
Cat. No.: pGMAD000579
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days
Pre-made Human SIRT1/SIR2/SIR2alpha adenoviral expression plasmid for SIRT1 adenovirus packaging, SIRT1 adenovirus.
Our GM-Adenovirus vector is optimized with the GMVC-modified Adeasy adenovirus packaging system. Find more about the GMVC-modified adenovirus packaging system.
Go to
SIRT1/SIR2 products
collection>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product Description
Catalog ID | pGMAD000579 |
Gene Name | SIRT1 |
Accession Number | NM_012238.4 |
Gene ID | 23411 |
Species | Human |
Product Type | Adenovirus plasmid (overexpression) |
Insert Length | 2244 bp |
Gene Alias | SIR2,SIR2alpha,SIR2L1 |
Fluorescent Reporter | RFP |
Mammalian Cell Selection | Null |
Fusion Tag | 3xflag (C-Terminal) |
Promoter | EF1 |
Resistance | Amplicin |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
---|---|---|
Target Antibody | GM-Tg-g-T14731-Ab | Anti-SIRT1 monoclonal antibody |
Target Antigen | GM-Tg-g-T14731-Ag | SIRT1 protein |
ORF Viral Vector | pGMLV000135 | Human SIRT1 Lentivirus plasmid |
ORF Viral Vector | pGMLV000525 | Human SIRT1 Lentivirus plasmid |
ORF Viral Vector | pGMLV000931 | Human SIRT1 Lentivirus plasmid |
ORF Viral Vector | pGMAD000463 | Human SIRT1 Adenovirus plasmid |
ORF Viral Vector | pGMAD000579 | Human SIRT1 Adenovirus plasmid |
ORF Viral Vector | pGMAP000577 | Human SIRT1 Adenovirus plasmid |
ORF Viral Vector | pGMLP-SPh-135 | Human SIRT1 Lentivirus plasmid |
ORF Viral Vector | pGMAP-SPh-275 | Human SIRT1 Adenovirus plasmid |
ORF Viral Vector | pGMPC000017 | Human SIRT1 Mammalian (Non-Viral Vector) plasmid |
ORF Viral Vector | pGMPC001352 | Human SIRT1 Mammalian (Non-Viral Vector) plasmid |
ORF Viral Vector | vGMLV000135 | Human SIRT1 Lentivirus particle |
ORF Viral Vector | vGMLV000525 | Human SIRT1 Lentivirus particle |
ORF Viral Vector | vGMLV000931 | Human SIRT1 Lentivirus particle |
ORF Viral Vector | vGMAD000463 | Human SIRT1 Adenovirus particle |
ORF Viral Vector | vGMAD000579 | Human SIRT1 Adenovirus particle |
ORF Viral Vector | vGMAP000577 | Human SIRT1 Adenovirus particle |
ORF Viral Vector | vGMLP-SPh-135 | Human SIRT1 Lentivirus particle |
ORF Viral Vector | vGMAP-SPh-275 | Human SIRT1 Adenovirus particle |
Target information
Target ID | GM-T14731 |
Target Name | SIRT1 |
Gene ID | 23411, 93759, 695682, 309757, 101087610, 489012, 613629, 100072571 |
Gene Symbol and Synonyms | SIR2,Sir2a,SIR2alpha,SIR2L1,SIRT1,sirtuin-1 |
Uniprot Accession | Q96EB6 |
Uniprot Entry Name | SIR1_HUMAN |
Protein Sub-location | Introcelluar Protein |
Category | Therapeutics Target |
Disease | Cancer |
Gene Ensembl | ENSG00000096717 |
Target Classification | Tumor-associated antigen (TAA) |
This gene encodes a member of the sirtuin family of proteins, homologs to the yeast Sir2 protein. Members of the sirtuin family are characterized by a sirtuin core domain and grouped into four classes. The functions of human sirtuins have not yet been determined; however, yeast sirtuin proteins are known to regulate epigenetic gene silencing and suppress recombination of rDNA. Studies suggest that the human sirtuins may function as intracellular regulatory proteins with mono-ADP-ribosyltransferase activity. The protein encoded by this gene is included in class I of the sirtuin family. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2008]
About GMVC
GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.